WSA
ELGX

Wall Street Associates’s Endologix Inc ELGX Stock Holding History

Wall Street Associates’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,514
Closed -$322K – 222
2016
Q3 		$322K Buy
+2,514
New +$322K 0.11% 186

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wall Street Associates's ELGX Position: Q4 2016 in Review

Wall Street Associates sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 2,514 shares — an estimated $322K sold.

Wall Street Associates first reported a position in ELGX in Q3 2016 and held it in 1 quarter. The position peaked at $322K in Q3 2016. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Wall Street Associates reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Wall Street Associates sold 2,514 Endologix Inc shares in Q4 2016, an estimated $322K.
  • Wall Street Associates first reported a position in Endologix Inc in Q3 2016 and held it in 1 quarter.
  • Wall Street Associates's Endologix Inc position peaked at $322K in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.